GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (OTCPK:ELVAF) » Definitions » Research & Development

Evolva Holding (Evolva Holding) Research & Development : $36.58 Mil (TTM As of Jun. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Evolva Holding Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Evolva Holding's Research & Development for the six months ended in Jun. 2023 was $32.11 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was $36.58 Mil.

Evolva Holding Research & Development Historical Data

The historical data trend for Evolva Holding's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding Research & Development Chart

Evolva Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.74 13.98 15.26 24.37 25.33

Evolva Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.84 6.78 20.03 4.48 32.11

Evolva Holding Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $36.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolva Holding  (OTCPK:ELVAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Evolva Holding Research & Development Related Terms

Thank you for viewing the detailed overview of Evolva Holding's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding (Evolva Holding) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (OTCPK:ELVAF) » Definitions » Research & Development
Comparable Companies
XSWX:KNRS XSWX:SPEX XSWX:ADXN XSWX:RLF OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
EVEz:UK EVE:Switzerland
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Website
https://www.evolva.com
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding (Evolva Holding) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research • 02-13-2024